49,024
edits
Line 4: | Line 4: | ||
*Lymphadenopathy associated with [[systemic lupus erythematosus]] (SLE). | *Lymphadenopathy associated with [[systemic lupus erythematosus]] (SLE). | ||
*Lymphadenopathy may be the first presentation of SLE.<ref name=pmid24048114>{{Cite journal | last1 = Smith | first1 = LW. | last2 = Petri | first2 = M. | title = Diffuse lymphadenopathy as the presenting manifestation of systemic lupus erythematosus. | journal = J Clin Rheumatol | volume = 19 | issue = 7 | pages = 397-9 | month = Oct | year = 2013 | doi = 10.1097/RHU.0b013e3182a6a924 | PMID = 24048114 }}</ref> | *Lymphadenopathy may be the first presentation of SLE.<ref name=pmid24048114>{{Cite journal | last1 = Smith | first1 = LW. | last2 = Petri | first2 = M. | title = Diffuse lymphadenopathy as the presenting manifestation of systemic lupus erythematosus. | journal = J Clin Rheumatol | volume = 19 | issue = 7 | pages = 397-9 | month = Oct | year = 2013 | doi = 10.1097/RHU.0b013e3182a6a924 | PMID = 24048114 }}</ref> | ||
Clinical DDx: | |||
*[[Lymphoma]]. | |||
==Microscopic== | ==Microscopic== |
edits